United Pharm (033270) — Capital Reinvestment Ratio
United Pharm (033270) has a Capital Reinvestment Ratio of 0.57x as of December 2025, meaning it reinvests 1% of its operating cash flow (₩23.01 Billion) in capital expenditures (₩13.11 Billion). See debt-free asset ratio of United Pharm to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
United Pharm Capital Reinvestment Ratio (2011–2025)
This chart tracks United Pharm's Capital Reinvestment Ratio across 14 annual periods. Check United Pharm cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for United Pharm (2011–2025)
Year-by-year Capital Reinvestment Ratio for United Pharm from 2011 to 2025. For live market cap and broader valuation context, see how much is United Pharm worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | ₩51.14 Billion | ₩25.14 Billion | ▼ -37.9% |
| 2024 | 0.79x | ₩26.79 Billion | ₩21.22 Billion | ▲ +25.9% |
| 2023 | 0.63x | ₩49.77 Billion | ₩31.31 Billion | ▲ +65.8% |
| 2022 | 0.38x | ₩63.78 Billion | ₩24.21 Billion | ▲ +30.8% |
| 2021 | 0.29x | ₩44.09 Billion | ₩12.79 Billion | ▼ -14.5% |
| 2020 | 0.34x | ₩36.96 Billion | ₩12.55 Billion | ▼ -34.5% |
| 2019 | 0.52x | ₩38.15 Billion | ₩19.76 Billion | ▲ +10.1% |
| 2018 | 0.47x | ₩36.86 Billion | ₩17.35 Billion | ▼ -52.8% |
| 2017 | 1.00x | ₩27.68 Billion | ₩27.59 Billion | ▲ +125.1% |
| 2016 | 0.44x | ₩30.02 Billion | ₩13.29 Billion | ▲ +17.3% |
| 2014 | 0.38x | ₩21.31 Billion | ₩8.05 Billion | ▼ -40.8% |
| 2013 | 0.64x | ₩18.97 Billion | ₩12.11 Billion | ▲ +14.8% |
| 2012 | 0.56x | ₩21.88 Billion | ₩12.16 Billion | ▲ +2.6% |
| 2011 | 0.54x | ₩27.62 Billion | ₩14.95 Billion | — |